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Abstract
Background: Wnt/β-catenin signaling is often portrayed as a simple pathway that is initiated by Wnt ligand at the
cell surface leading, via linear series of interactions between ‘core pathway’ members, to the induction of nuclear
transcription from genes flanked by β-catenin/TCF transcription factor binding sites. Wnt/β-catenin signaling is also
regulated by a much larger set of ‘non-core regulators’. However the relationship between ‘non-core regulators’ is
currently not well understood. Aberrant activation of the pathway has been shown to drive tumorgenesis in a
number of different tissues.
Methods: Mammalian cells engineered to have a partially-active level of Wnt/β-catenin signaling were screened
by transfection for proteins that up or down-regulated a mid-level of TCF-dependent transcription induced by
transient expression of an activated LRP6 Wnt co-receptor (ΔNLRP).
Results: 141 novel regulators of TCF-dependent transcription were identified. Surprisingly, when tested without
ΔNLRP activation, most up-regulators failed to alter TCF-dependent transcription. However, when expressed in
pairs, 27 % (466/1170) functionally interacted to alter levels of TCF-dependent transcription. When proteins were
displayed as nodes connected by their ability to co-operate in the regulation of TCF-dependent transcription, a
network of functional interactions was revealed. In this network, ‘core pathway’ components (Eg. β-catenin, GSK-3,
Dsh) were found to be the most highly connected nodes. Activation of different nodes in this network impacted
on the sensitivity to Wnt pathway small molecule antagonists.
Conclusions: The ‘functional connectome’ identified here strongly supports an alternative model of the Wnt
pathway as a complex context-dependent network. The network further suggests that mutational activation of
highly connected Wnt signaling nodes predisposed cells to further context-dependent alterations in levels of
TCF-dependent transcription that may be important during tumor progression and treatment.
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Background
Wnt signaling plays a crucial role in normal develop-
ment and disease. Deregulated Wnt signaling has
been implicated in cancers arising in many different
tissues [1]. Wnt ligand binding to Fz/LRP co-
receptors inhibits β-catenin turnover leading to the
activation of β-catenin/TCF-dependent transcription
and target genes including c-myc [2, 3]. In colon can-
cer, mutations in pathway components have been
identified in the majority of tumours [1, 3–5].
Enhanced Wnt signaling drives increased cell prolifer-
ation, decreased differentiation and the formation of
adenomas [4, 6]. In breast cancer, mutations to path-
way components are rare despite the observation that
β-catenin is aberrantly stabilised in over 50 % of
tumours. Epigenetic changes leading to altered ex-
pression of Wnt pathway regulators has been
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suggested to drive tumorigenesis in cancers lacking
well defined mutations [6–8].
The classic Wnt signaling pathway can be presented as
a simple linear pathway involving the following ‘core’ com-
ponents: Wnt/Fz/LRP→Dsh–|Axin/APC/GSK-3–|β-cate-
nin→TCF. However, this linear view does not convey the
degree of complexity suggested by screens in D. melano-
gaster, HeLa and colon cancer cells that have identified
over 250 genes as regulators of TCF dependent transcrip-
tion [7, 9–12]. In many cases the mechanism(s) by which
newly-identified regulators interact with ‘core’ pathway
components is unknown. This may, in part, be be-
cause their mechanism(s) of action are context-
dependent [9, 11–14]. Given the number of Wnt/β-
catenin pathway regulators that have been identified
in screens, a key challenge is the prediction of
whether any particular gene product will regulate
Wnt signaling in each of multiple potential cell
contexts.
This study describes a screen that identified known
and novel cDNAs that up- and down-regulated TCF-
dependent transcription. Pair-wise combinations of
genes were found to synergise in their induction of TCF-
dependent transcription and large-scale mapping of
these synergistic interactions uncovered a network of
functional interactions. The structure of the Wnt net-
work highlights potential mechanisms of functional syn-
ergy in cancer cells and can be used to identify novel
points for therapeutic intervention.
Results and discussion
To identify novel regulators of Wnt signaling, a highly-
inducible HEK293 based TCF-luciferase reporter cell
line, with low levels of basal Wnt activity (7df3, [6–8]),
was used to screen an expression library of 9000 full-
length cDNAs from Xenopus tropicalis [7, 9–12]. An
overview of this and subsequent experiments is shown
in Fig. 1. To identify both positive and negative regu-
lators, a constitutively active form of the Wnt LRP6
co-receptor (ΔNLRP), which induced a mid-level of
transcription (~15-fold activation; Fig. 2a), was co-
transfected with each pool of 3 cDNAs (3000 pools of
3 cDNAs). This approach allowed the identification of
modulators that could contribute to a ‘just right’ level
of Wnt pathway activity as found in tumours [15].
Luciferase reporter activity was normalised to expres-
sion from a co-transfected CMV-LacZ plasmid. A set
of 151 inhibitor and 139 inducer cDNA pools were
selected based on a combination of their fold induc-
tion/repression and their variation from the plate
mean (Additional file 1: Figure S1). Assaying the indi-
vidual cDNAs from hit pools identified 45 inducers
and 96 inhibitors (example inducers and inhibitors
are shown in Fig. 2b, c and a full list is presented in
Additional file 2: Table S1). No correlation between
CMV-LacZ expression and luciferase activity was ob-
served, suggesting that cDNAs did not affect general
transcription. cDNAs encoding the known Wnt path-
way modulators CK1ε, CK1δ, Dvl2 and Axin2 were
identified, confirming the screen identified Wnt
regulators.
One of the strongest inducers (12.7 fold; Additional
file 2: Table S1) was the Xenopus Tropicalis cDNA for
the gene Prune. When assayed in the cognate Xenopus
laevis animal cap explant system, Prune induced expres-
sion of Siamois, a classic Wnt/β-catenin target. In
addition, Prune induced partial axis duplication in ven-
trally injected embryos (Additional file 3: Table S2), a
phenotype that is consistent with the activation of the
Wnt signaling pathway in X. laevis. PRUNE is amplified
and overexpressed in breast cancer [9, 11–14, 16] while
Wnt/β-catenin signaling is particularly activated in triple
negative breast cancer (TNBC) [13, 17]. To determine if
Prune was required for Wnt signal transduction we re-
duced PRUNE levels in the TNBC breast cancer cell line
MDA-MB231 by siRNA transfection. MDA-MB231 cells
Fig. 1 A schematic overview of the screening and pairwise assays
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have raised levels of endogenous β-catenin [18] and
knock down of PRUNE led to a 40 % decrease of active
(i.e. unphosphorylated) β-catenin levels that was equiva-
lent to that induced by an siRNA to β-catenin itself
(Fig. 2d-f ). Taken together the data suggest that Prune
may regulate Wnt/β-catenin signaling in an oncogenic
context.
Wnt pathway activators
To further validate function, the activators were
expressed in HCT116 colon cancer cells that contain an
endogenous activated β-catenin allele, significant pro-
portions of which are present in membrane-bound com-
plexes [19], and show a mid-level of TCF-reporter
activity as determined by co-transfection with the TOP-
flash plasmid. After using the Benjamini-Hochberg
method [20, 21] to correct for multiple hypothesis test-
ing, 14 of the 45 activators were found to further
increase (super-activate) reporter levels (Benjamini-
Hochberg corrected p-values ranged from p = 3.4 × 10−3
to p = 6.6 × 10−28; Fig. 3a, Additional file 4: Table S3).
Thus the ability to super-activate transcription was
shared by a significant subset of genes initially identified
in the HEK293-based reporter cell line.
A subset of the strongest activators were assayed in X.
laevis secondary axis induction experiments, and for the
ability to activate the Wnt target genes Xnr3 and
Siamois in a X. laevis animal cap assays. RNAs that in-
duced the formation of a complete secondary axis
(HMX2, HMGB3, HRAS, EMX2, HMGB1, ZNF616, and
HDGF) also strongly induced expression of Wnt target
genes (Fig. 3b, Additional file 3: Table S2). Interestingly,
HMGB1 and HMGB2 have previously been linked to
altered Wnt signaling in cartilage development, provid-
ing further support linking the set of genes to Wnt
signalling [2, 22].
Wnt pathway inhibitors
The 96 inhibitory cDNAs identified in the screen were
assessed for their effects in two different colon cancer lines.
When transfected into SW480 cells that have high levels of
‘active’ b-catenin and highly active TCF dependent tran-
scription following APC deletion, nearly half (42/96) of the
inhibitors reduced TCF-dependent transcription (Benja-
mini-Hochberg corrected p < 0.01; Additional file 4: Table
S3, Fig. 3c; [23]). By contrast, only 15/96 cDNAs showed
significant inhibition of TCF-dependent transcription in
HCT116 cells that contain mutant, constitutively active
β-catenin (Benjamini-Hochberg corrected p < 0.01; Add-
itional file 4: Table S3, Fig. 3d). Eight of the inhibitors were
active in both cell lines, and 4 were able to inhibit TCF-
dependent transcription by greater than 50 % in both cell
lines (TBPL1, IDH2, SFRS3, RXRβ). The distinct responses
to inhibitor expression in the different lines suggested a
context dependence of cellular responses.
Functional interactions between cDNA pairs
To determine the capacity of the 45 activators to increase
TCF dependent transcription independently of ΔNLRP,
they were individually transfected into the 7df3 reporter
cells (Fig. 4a; Additional file 5: Table S4). Surprisingly, 40/
45 failed to activate TCF-dependent transcription when
assessed alone ((K-S) test, p < 0.01). Five cDNAs (Prune
homolog (PRUNE2), Dishevelled (DVL2), Casein kinase
1ε (CSNK1E), Mesoderm posterior (MESPA) and Casein
kinase 1δ (CSNK1D)) induced TCF-dependent transcrip-
tion above background levels (Fig. 4a). Four of these acti-
vators satisfy a Benjamini and Hochberg corrected p-value
of <0.05, whereas the final activator identified using an un-
corrected p-value of <0.01 (CSNKD) had a corrected p-
Fig. 2 Identification of novel Wnt regulators. a Dose-dependent
induction of TCF dependent transcription in 7df3 cells by constitutively
active LRP6 (ΔNLRP). b and c Examples of the 45 inducers (b) and 96
inhibitors (c) of TCF-dependent transcription identified from a cDNA
library screen of 9000 Xenopus tropicalis cDNAs (see Additional file 1:
Figure S1). d Prune siRNA reduced h-Prune protein levels. FLAG-tagged
h-Prune was transfected into MDA-MB231 breast cancer cells 24 h after
transfection of either Renilla luciferase or Prune siRNA. Expression was
detected with an anti-FLAG antibody. e Knockdown of Prune by siRNA
reduced the level of active (de-phosphorylated) β-catenin in MDA-
MB231 cells. Blot shown is representative of four separate experiments.
f Levels of active β-catenin after siRNA transfection in 4 separate exper-
iments were quantified. Knockdown of Prune reduces levels of de-
phosphorylated β-catenin to a level that was not significantly different
from the knockdown of β-catenin (Student’s T-test, p < 0.05)
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value of 0.052. Dishevelled and Casein kinases 1ε and δ
have previously been implicated in the modulation of Wnt
signaling [24].
Up until this point, any cDNA identified through its
ability to super-activate TCF-dependent transcription
was described as an inducer. From this point on, cDNAs
that individually activated TCF-dependent transcription
will be referred to as activators, while those that re-
quired the co-expression of other cDNAs such as
ΔNLRP for their activity to be apparent will be identified
as enhancers.
The conditional dependence of 40 out of the initial 45
activating cDNAs on ΔNLRP expression raised the ques-
tion as to whether their ability to enhance TCF-
dependent transcription was specific to ΔNLRP or
whether they could enhance TCF-dependent transcrip-
tion in combination with other activators or enhancers.
To explore this question, the 40 enhancers and 5 activa-
tors identified in the screen were co-transfected with
each other and with a further 4 constitutive ‘core’
activators (Fig. 1). The additional ‘core activators’ of
Wnt signaling comprised a form of β-catenin lacking the
N-terminal phosphorylation domain (ΔNβCAT), the
GSK-3 binding domain of Axin (AxinGID), a VP16
transactivation domain fused to full length TCF4 (VP16-
TCF) and a VP16 transactivation domain fused to the
minimal HMG box DNA binding domain of TCF
(VP16-minTCF) [8]. In total 1170 pairwise combinations
were assayed for synergy. As some ‘core’ activators were
individually capable of inducing high levels of TCF-
dependent transcription, the amounts of the ‘core’ acti-
vator’s cDNAs were reduced to induce a mid-range
induction of reporter activity (Fig. 4a; ΔNLRP-induced
levels were defined as 100).
The 1170 combinations were assessed to identify if
they were significantly different from background (K-S
test; p < 0.01) before a weight was assigned to each com-
bination. The weight quantifies the experimental synergy
between two co-transfected cDNAs by comparison with
the reporter activity induced by each cDNA of the pair
Fig. 3 Transcription regulation in colon cancer cells and Xenopus laevis. a Example ‘inducer’ cDNAs effect on TopFlash reporter when co-transfected
into HCT116 cells (see Additional file 4: Table S3 for complete list). Comparison with the mutant FopFlash reporter demonstrates high basal levels of
β-catenin/TCF-dependent transcription. Results are from triplicate wells across different plates. Stars represent statistical significantly different values
from TopFlash (Benjamini-Hochberg corrected p < 0.01). b Expression of a subset of ‘inducers’ activated transcription of the endogenous Wnt target
genes Xnr3 and Siamois in animal cap assays. AC; uninjected animal caps. ODC; ornithine de-carboxylase control. c and d TopFlash
reporter activity from a subset of cDNAs co-transfected into SW480 cells (c) or HCT116 cells (d). (see Additional file 3: Table S2 for
complete a list). The data shown are from triplicate wells across different plates. Stars represent statistically significantly different values
from TopFlash (Benjamini-Hochberg corrected p < 0.01)
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when expressed alone, as described in Methods. Using
a cut-off that satisfies a Benjamini and Hochberg cor-
rected p-value of <0.03, 315/1170 pairwise cDNA
combinations showed significantly higher levels of
TCF-dependent transcription and 151 showed signifi-
cantly lower levels than expected if there were no
functional interaction (Fig. 4b, c). None of the syner-
gistic interactions correlated with changes in expres-
sion from the co-transfected CMV driven LacZ
reporter, suggesting that the functional interactions
were specific for β-catenin/TCF-dependent transcrip-
tion. The results were displayed as a heat map and as
Fig. 4 A network of functional interactions that modulate TCF-dependent transcription. a Reporter activity of cDNAs individually transfected into 7df3
cells. Green circles represent constitutively active versions of ‘core’ pathway members. The 5/45 cDNAs that were able to activate TCF dependent
transcription to a level greater than background (Kolmogorov-Smirnov test, p < 0.01) are shown in blue. All other cDNAs were unable to activate TCF
dependent transcription when individually transfected and are shown in black. ΔNLRP levels of activation were defined as 100. b Heat map displaying
functional interactions. Red and blue squares indicate positive or negative interaction respectively. The opacity of the colour indicates the strength of
the interaction. c Network visualisation of functional interactions. Positive (red) and suppressive (blue) interactions whose strength is represented by line
opacity are displayed. Core nodes are coloured green, activator nodes are blue whilst enhancers are black. The core pathway members tend to be the
most highly connected nodes. d and e Synergistic interactions were observed using promoter-reporters driven by the endogenous Wnt target genes
Myc (d) or Siamois (e) in HEK293 cells. All combinations with the exception of Ras/CK1δ and the Siamois promoter showed (multiplicative)
synergistic responses
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a network in which cDNAs were depicted as nodes
and synergy as links (Fig. 4b, c). Synergistic interac-
tions were very common, but were not evenly distrib-
uted. In particular, activator nodes including ‘core’
pathway components were most highly connected
(Additional file 6: Figure S2). Synergistic interactions
between cDNA pairs were also observed in the regu-
lation of the Wnt target promoters c-Myc and
Siamois, suggesting that functional interaction was
not restricted to reporters containing artificial multi-
merized TCF-binding elements (Fig. 4d, e).
The Xenopus PRUNE phosphodiesterase was the
strongest novel activator in the absence of ΔNLRP
(Fig. 4a). By contrast, human PRUNE, perhaps due to its
use at its physiological temperature was incapable of ac-
tivating TCF-dependent transcription (Fig. 5a). However,
Fig. 5 Functional interrogation of interacting pairs. a h-Prune synergy with HRAS was reduced following mutation of h-Prune catalytic residues
(Prune 4Ddelta) [40]. Activation by cDNAs pairs (b) and inhibition by anti-Wnt signaling compounds (c) Compounds were added at 5 times their
IC50 48 h after transfection. Luciferase assays were carried out 24 h later and were normalised to CMV-lacZ levels
Freeman et al. Molecular Cancer  (2015) 14:206 Page 6 of 14
when human PRUNE was assessed in combination, it
synergised with 19/45 cDNAs. These included both
CSNK1D and CSNK1E which have previously been
linked to Prune and its direct binding partner, the me-
tastasis suppressor nm23-H1 (Fig. 5a, Additional file 7:
Figure S3) [25]. PRUNE’s phosphodiesterase activity has
been implicated as a target for the tumour progression
phenotype associated with ASAP1 [26]. Point mutations
within human PRUNE’s cAMP phosphodiesterase
domain resulted in lower levels of TCF-dependent tran-
scription suggesting that functional interaction relied at
least in part on the phosphodiesterase activity (Fig. 5a).
Using the functional connectome to study drug action
The pairs of inducers of β-catenin/TCF-dependent tran-
scription should allow therapeutic agents to be tested in
a defined cellular background (7df3 cells) against regula-
tor combinations that would normally be activated in
specific cellular contexts such as cancer cells. To explore
this potential, known activators as well as two cDNA
pairs (HDGF/MESP, CSNK1E/KRAS) were transfected
into 7df3 cells and treated with a number of compounds
for 24 h prior to luciferase reporter assay (Fig. 5b, c).
ICG001 is known to interfere with β-catenin-CBP inter-
actions (required for transcriptional transactivation) [27],
XAV939 and IWR-2 promote β-catenin degradation by
stabilising Axin [28], Senexin A inhibits the kinase CDK8
[29] while the molecular target(s) of CCT036477 and
CCT070535 have not yet been identified [8]. TCF-
dependent transcription induced by the cDNA combina-
tions showed different sensitivity to inhibition by the small
molecules (Fig. 5b, c). Transcription induced by the
CSKN1E/NRAS and CSKN1E alone was fully inhibited by
CCT036477 when used at five times the concentration re-
quired to block transcription induced by an activated
Dvl2-ER fusion protein [8]. By contrast, this combination
was less affected by CCT70535. Other activating pairs
such as the HDGF/MESPA combination was largely re-
sistant to inhibition by both CCT036477 and CCT70535,
suggesting that the expression of HDGF in a subset of
colon cancers may be a negative prognostic biomarker for
CCT070535-related therapies [30]. ICG001 showed very
broad efficacy, while XAV939 and IWR-2 were ineffective
against mutant β-catenin as would be expected from their
mechanism of action; both showed partial efficacy against
other cDNA combinations. Taken together, these studies
suggest that combinations of activators and enhancers
might in future help predict biomarkers whose overex-
pression confers sensitivity or resistance to Wnt pathway
therapeutic agents.
Functional interactions in colon cancer cells
To investigate whether the network of functional inter-
actions identified in the 7df3 cells was observed in other
cell types a subset of cDNA nodes identified in the 7df3
reporter cells was examined for functional interaction in
HCT116 cells (Fig. 6). HCT116 cells were transiently co-
transfected with pair-wise combinations of 8 cDNAs
together with the TopFlash reporter. 26/28 total possible
interactions were detected in HCT116 cells (Fig. 6b, c).
This number comprised many more functional interac-
tions than observed between the same cDNAs in the
7df3 reporter line (Fig. 6a). Some cDNA pairs did not
functionally cooperate in either 7df3 or HCT116 cells
(Eg. HRAS-MESPA) suggesting that underlying mecha-
nisms of functional interaction may be conserved.
Comparison of sets of Wnt regulators
To derive further mechanistic insight into the reasons for
the selective patterns of functional interaction (Fig.7a, b),
the overlap between the functional connectome and pro-
tein interactions was investigated. A focused Wnt Protein
Interaction Network (PIN) was constructed based on gene
lists of ‘Wnt regulators’ from four screens. These com-
prised an siRNA screen in the 7df3 cells (submitted manu-
script), two siRNA screens in colon cancer [11, 12] and
human homologues of the modulators identified in this re-
port (Additional file 8: Table S5). These functionally identi-
fied regulators were used to interrogate the STRING
protein interaction database [31] (experimental data only)
to produce a protein interaction network comprising 699
nodes connected by 1846 links (grey lines). Community
detection identified 20 different candidate protein com-
plexes from the set of Wnt modulators (Louvain method
for modularity maximization [32]; Fig. 7c, (Additional
file 7: Table S3, Additional file 9: Figure S4, Additional
file 10: Table S6). 16 of the functional connectome
nodes identified in this study were present in the PIN,
distributed amongst 8 complexes.
A prospective analysis suggested that there were more
links between communities (candidate protein complexes)
than within the same communities than would be expected
by chance. This analysis compared the PIN community
membership of the connectome’s links to shuffled versions
of the connectome, (Additional file 11: Figure S5). Across
the range of available thresholds the Z-score comparison
of the actual connectome to the randomized versions was
always positive (Additional file 11: Figure S5). This increase
in links between communities supports the idea that func-
tional interactions preferentially involved components of
different protein complexes.
Conclusions
In this report we identified 45 inducers and 96 inhibitors
of TCF-dependent transcription using a cDNA expres-
sion screen. Known and novel regulators of Wnt signal-
ing were identified. These included Prune, which is
amplified in breast cancer [33] and was shown here to
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be required for the stabilisation of active β-catenin in
MDA-MB231 breast cancer cells. Both inducers and in-
hibitors altered the absolute level of TCF-dependent
transcription. The importance of the level of Wnt pathway
activity has been highlighted by a study correlating discrete
thresholds of activation with distinct developmental and
Fig. 6 Comparison of functional network structure in 7df3 and HCT116 cells. a Pattern of functional interaction between a subset of cDNAs in
7df3 TCF-luciferase reporter cells. The thickness of the line represents the relative strength of the synergy. b Pattern of functional interaction in
HCT116 cells. Functional interaction between cDNAs is indicated by a line between the relevant nodes when the activity of cDNA pairs exceeded
the product of the reporter activity for each cDNA when expressed individually (Student’s t-test, p < 0.01). c Functional interaction between
HMGB3/NUCKS1, and IRX3/HDGF in HCT116 cells
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Fig. 7 (See legend on next page.)
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oncogenic outcomes [34]. The overexpression (or loss of
expression) of these regulators in cancer may modulate the
absolute level of Wnt signaling such that levels that are ‘just
right’ for discrete steps in oncogenic progression [35].
The conditional activation of TCF-dependent tran-
scription with ΔNLRP prompted an analysis of coopera-
tivity between multiple Wnt regulators. 466 of a possible
1170 pairwise combinations functionally interacted
either positively or negatively. A key feature of the func-
tional connectome was the non-overlapping patterns of
functional connectivity (Fig. 7b). The mutually exclusive
interaction patterns argue that non-overlapping cDNA
pairs function via distinct underlying mechanisms. The
pattern of interactions observed was termed a ‘functional
connectome’ and can be displayed as a network graph
(Fig. 4). Previous studies of Wnt regulators have identi-
fied enhancers and repressors of single-gene phenotypes
such as APC-dependent tumorigenesis [36], but have
not examined multi-gene interactions. Analogous
pairwise-interaction studies have been carried out in
yeast and Drosophila cells although synthetic lethality
was a primary readout [37].
The functional connectome was derived from interac-
tions that were identified in one reporter cell line. Nonethe-
less, many positive and negative interactions were also
observed in the colon cancer cell line HCT116 suggesting
that interactions and the lack of interaction may be con-
served. Furthermore, functional interactions were restricted
to less than 50 % of all potential interactions, suggesting
that the network preserves context-dependence that may
characterise the diverse array of cellular systems in which
Wnt signaling functions. The functional connectome may
then best be used as a map of potential interactions that
can be used to guide studies based on the expression of
network nodes.
Highly connected network nodes and the ‘core pathway’
An observation from siRNA screens for novel Wnt sig-
naling regulators was that ‘core’ pathway components
were selectively enriched in the small subset of genes
that were identified in more than one cell line. The func-
tional connectome can help explain how proteins come
to be regarded as ‘core’ components [1]. The structure of
the functional connectome would suggest that a func-
tional interaction between two gene products (A and B)
would be observed following gene product ‘A’ depletion
or overexpression only if its interacting partner ‘B’ were
present/expressed. The degree of connectivity of the
node would be critical. For example, expression of the
transcriptional repressor SNAI2, as a relatively poorly
connected node, might only modulate TCF dependent
transcription in a cellular background in which one of
its cooperating partners was expressed. By contrast
changes to CK1ε levels/activity, as a well-connected
node, would have a higher probability of altering Wnt
signaling due to the greater probability of its interacting
partners being expressed. On a probabilistic basis, highly
connected, ubiquitously-expressed nodes would be most
likely to be identified in multiple cell contexts. It is
therefore possible that the concept of a ‘core’ Wnt path-
way, which integrates results from multiple model sys-
tems, represents a statistical sample of a subset of
highly-connected Wnt signaling nodes.
Functional interactions in tumour cells
Fourteen enhancers super-activated TCF dependent tran-
scription when transfected alone into HCT116 colon can-
cer cells (Fig. 3a, Additional file 4: Table S3). HCT116
cells already have raised levels of TCF-dependent tran-
scription due to an activated β-catenin allele and autocrine
Wnt signaling [18]. The promiscuous functional connec-
tions observed in HCT116 cells suggest that levels of
TCF-dependent transcription may be more easily modu-
lated once the pathway has initially been activated. Once
the pathway has been activated by an initial mutation,
the availability of many additional mechanisms for
further pathway modulation may help melanomas,
colon and liver cancers maintain ‘just right’ levels of
Wnt signaling that have been proposed to be import-
ant for tumour formation [34, 35].
Integrating functional and protein interaction networks
While a detailed mechanistic analysis of the interaction
patterns observed is beyond the scope of this study, a ra-
tionale for functional connectivity was suggested when
overlaps with protein interaction networks were explored
(Fig. 7c, Additional file 11: Figure S5). Our analysis
supported the hypothesis that functional connections pref-
erentially linked proteins between discrete protein commu-
nities rather than proteins within a community [38] (Fig. 7,
Additional file 9: Figure S4). As protein communities have
been related to multiprotein complexes, and therefore to
(See figure on previous page.)
Fig. 7 Non-overlapping interaction patterns and protein interaction networks. a Data from a subset of the 7df3 network displayed in more detail
to highlight an important feature of the network; that functional co-operativity is limited to selected enhancer combinations. b Further examples
of simple non-overlapping sub-networks. c Overlay of the ‘functional connectome’ on a Wnt PIN. Twenty protein communities (coloured nodes
with grey links indicating protein interaction) were identified by modularity maximisation using the Louvain method. To guide the eye the layout
algorithm emphasises these communities and only positive functional connections with a link weight greater than 1.5 are shown with opacity
reflecting the strength of interaction
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distinct molecular processes, this supports the idea that
functional connections are more likely through alterations
to distinct processes.
Protein overexpression can activate or inhibit the func-
tion of multiprotein complexes by titrating interacting
components. The functional connectome may therefore
represent a map of molecular processes that cooperate to
regulate TCF-dependent transcription. Although nodes
may not be physiological targets, they may nonetheless
highlight molecular processes/protein complexes that
synergise to generate graded levels of TCF-dependent
transcription [34]. Functional connection patterns may
also be helpful as a guide to potential mechanisms of ac-
tion. For example, nodes with identical patterns may act
through similar mechanisms. Likewise, similar patterns of
activity of therapeutic inhibitors may be used to infer simi-
lar mechanisms of action. In the longer-term, the gener-
ation of larger networks and additional quantitative
readouts should allow a greater level of prediction of
context-specific signaling including the multiple novel
genetic interactions observed in tumorigenesis [39].
Therapeutic targeting of Wnt signaling
The list of novel Wnt pathway regulators identified by this
and other screening approaches offer a range of potential
targets for therapeutic intervention. Both Prune and HDGF
are overexpressed in breast and colon cancers [30, 33, 40].
The phosphodiesterase activity of Prune may be well suited
to the development of small molecule inhibitors, whilst
antibodies to HDGF may be useful in the treatment of colo-
rectal and liver cancer where it has been shown to act as an
extracellular mitogen [30, 41]. H-ras and K-ras are primar-
ily known for their oncogenic activation of MAP kinase sig-
naling. However their identification here as Wnt enhancers
is consistent with studies showing that MAP kinase signal-
ing can modulate Wnt/β-catenin signaling and may be
essential for the expression of Wnt target genes and
tumour progression in colorectal cancer [42, 43].
The genetic uniqueness of individual cancers with re-
spect to Wnt/TCF-dependent transcription signaling cre-
ates a dilemma for efforts to therapeutically target the
pathway. Severe ‘off-target’ effects are predicted if ‘core’
pathway components are targeted given the homeostatic
requirement for Wnt signaling in multiple tissues [44, 45].
The patterns of cooperativity identified in the functional
connectome might be used to suggest combinations of in-
hibitors that enhance Wnt-specific phenotypic outputs
whilst minimizing off-target toxicities [46].
Methods
Cell culture
All cells were cultured at 37 °C and 5 % CO2 in DMEM
supplemented with 10 % heat inactivated Fetal Calf
Serum, 50 units/ml Penicillin, 50 μg/ml Streptomycin
and 0.5 % L-Glutamine 50 mg/ml (all from Gibco). 7df3
cells were maintained under constant antibiotic selection
using 200 μg/ml hygromycin (Invitrogen) and 3 μg/ml
blasticidin (Invitrogen). The identity of the SW480 and
HCT116 lines was confirmed by DNA fingerprinting.
DNA transfections and luminescence assays
Cells were transfected in 96-well format with 100 ng of
plasmid DNA comprising CMV-driven cDNAs from the
Xenopus Tropicalis library, the normalization control
plasmid CMV-lacZ or the ‘filler’ plasmid pCDNA3.1 that
also contains a CMV promoter. Transfection was per-
formed using the Transfectin (BioRad) reagent according
to manufacturers instructions. Assays were performed
48 h post transfection. Luciferase and galactosidase assays
were performed using the Bright-Glo or Beta-Glo systems
(Promega) respectively according to manufacturers in-
structions and assayed using a FluoStar Optima plate
reader (BMG Labtech). β-catenin antibodies were used at
1/1000 dilution and were from BD Transduction Labs
(Clone 14) and Merck Millipore (anti-ABC b-catenin
clone 8E7). The anti-Flag (clone M2) antibody was from
Sigma.
Hit selection
Mean reporter activity was normalised as both a fold of
the plate mean, and as the number of standard devia-
tions away from the plate mean. The 100 most activating
and 100 most inhibiting pools from each analysis were
selected for deconvolution. To identify the responsible
cDNA(s) within each well, each plasmid was co-
transfected with ΔNLRP in triplicate. Hits that were
significantly different from 36 ΔNLRP control wells (12
wells/96 well plate) were identified using a student’s
two-tailed t-test (p < 0.01).
Network studies
To identify and investigate synergistic interactions of co-
expressed genes on the integrated β-catenin/TCF-re-
porter present within the 7df3 cells, we adopted a meth-
odology based on that of Mani et al. for enumeration of
genetic interaction [47]. Our observable output was a set
of luminescence values indicating reporter activity.
Luciferase values from individual (A or B) and pairwise
(A co-transfected with B) cDNA combination in 7df3
cells (3–6 replicates) were first normalised to CMV-lacZ
reporter levels and compared to background reporter
activity from cells transfected with the pCDNA3.1 plas-
mid (n = 6–12 per 96-well plate).
The sets of values under scrutiny when evaluating the
synergistic interaction between cDNAs A and B com-
prise the data obtained when A is expressed in isolation,
when B is expressed in isolation and when both A and B
are co-expressed. Additionally, we also recorded a
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background (control) scenario where no expression plas-
mid was expressed (other than the co-tranfected CMV-
lacZ and ‘filler’ pCDNA3.1 control). We first computed
the mean luminescences μA, μB and μA, B for each
cDNA expressed in isolation and the pairwise co-
expression (3–6 replicates). The datasets for each indi-
vidual and the pairwise luminescences were compared
to the control luciferase reporter activity. Those data-
sets that were not statistically significantly different
(Kolmogorov-Smirnov (K-S) test; p < 0.01) including
those with means higher than background were set to
the background level. Datasets significantly different
from background but with means lower than back-
ground were also set to the background level. This
prevented the propagation of anomalies deriving from
low-level fluctuations in reporter activity.
A network link weight (strength) for the synergistic
interaction between nodes (cDNAs) A and B when co-
expressed was then written:
Wa;b ¼ loge
μa;b
max μa; μbð Þ
 
This enumeration of interaction has a number of salient
properties. It prescribes positive link weights for synergis-
tic interactions and negative weights for antagonistic in-
teractions. A synergistic interaction is one in which
pairwise co-expressed activity was greater than both indi-
viduals (i.e. the presence of one of the cDNAs enhanced
the activity of the other). If only one of the pair activated
when individually expressed, any increase above this
would constitute a positive interaction. Similarly, if neither
cDNA led to an increase in reporter activity above back-
ground levels when individually expressed, any reporter
activity above background levels upon co-expression
would constitute a synergistic interaction.
A negative link weight was prescribed for suppressive
interactions in which pairwise activity is less than either
one of the individuals. Consequently, if two cDNAs were
co-expressed and either (or both) was capable of indu-
cing reporter activity individually and the pairwise activ-
ity was lower than the maximum individual level, a
negative link weight was assigned. The use of the loga-
rithm ensured that the magnitudes of the multiplicative
interactions are consistent between positive and negative
synergies and that where no enhancement or suppres-
sion was observed; a zero edge weight was assigned (see
Additional file 12: Supplementary Methods for details of
mathematical analyses and model selection).
Protein and functional interaction networks
A protein interaction network was generated from the
list of Wnt-regulators (Additional file 8: Table S5) and
first-degree protein interaction nodes as derived from
the STRING database (see main text for details). Com-
munity detection algorithms were used to partition pro-
tein interaction network members (PIN) into groups of
nodes (communities). See Additional file 12: Supplemen-
tary methods for further details. The subset of the func-
tional connectome that had proteins in common with
the PIN comprised 16.
Each functional connectome link was either between
nodes in different PIN communities or lay within a com-
munity. To compare the number of connectome links
that lay within and between PIN communities, the
experimental connectome links were repeatedly ran-
domized amongst the connectome nodes, in a fashion
that preserved the degree of individual nodes (Maslov
Sneppen method [20]. From this, a distribution of the
number of inter-community links was created that
was representative of a randomly selected network
with the same degree sequence. The observed number
of inter-community links in the original connectome
was compared to this distribution via a z-score.
We further extended this comparison by considering
only the strongest connectome links. We chose a thresh-
old, τ, and retained only those connectome links with a
weight greater than this threshold before repeating the
randomization procedure.
Analysis of cDNA inhibitors in cancer cell lines
Candidate inhibitor cDNAs were co-transfected with the
TOPflash luciferase reporter in triplicate and were nor-
malised to FOPflash (A control vector corresponding to
TOPflash but instead containing scrambled TCF binding
sites [2, 3]. A student’s two-tailed t-test and a Benjamini-
Hochberg corrected significance cut-off of 0.01 was used
to identify cDNAs capable of inhibiting TCF-dependent
transcription driven by β-catenin mutation in HCT116
cells or by APC deletion (SW480).
Functional analysis in Xenopus laevis
X. laevis embryos were obtained, cultured and injected
as described [1, 3–5]. Experiments were carried out with
relevant UK animal licence and ethical approvals.
Capped mRNA for injection was prepared from the
cDNA using the mMessage mMachine kit (Ambion),
and purified using illustra ProbeQuant G-50 Micro Col-
umns (GE Healthcare). RNA was purified and RT-PCR
was performed as described [4, 6].
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